FDA Office of Prescription Drug Promotion (OPDP) · United States
FDA OPDP DTC Pharma Fair Balance Requirements
Prescription drug ads that name a drug and its use must present risk information with prominence comparable to benefit claims and must not overstate efficacy or safety.
What is FDA OPDP DTC Pharma Fair Balance Requirements?
Prescription drug ads that name a drug and its use must present risk information with prominence comparable to benefit claims and must not overstate efficacy or safety. Apply to any consumer-directed prescription drug product-claim ad or promotional piece in any US channel.
general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
1985-09-09
What does this rule require?
Prescription drug ads that name a drug and its use must present risk information with prominence comparable to benefit claims and must not overstate efficacy or safety.
How can marketing teams comply?
Apply to any consumer-directed prescription drug product-claim ad or promotional piece in any US channel.
What is FDA OPDP DTC Pharma Fair Balance Requirements?
Prescription drug ads that name a drug and its use must present risk information with prominence comparable to benefit claims and must not overstate efficacy or safety.
Who does this rule apply to?
general_audience, general_adults_18plus, customers, patients · Prescription Drug · pharma
Drug firms may not promote prescription drugs for unapproved uses; scientific information on unapproved uses may go to HCPs only if separate from promotion and accompanied by the disclosures in FDA's 2025 guidance.
Swiss real estate fund marketing must be identifiable as advertising, refer to the prospectus and KID, present performance fairly with a past-performance caveat, disclose key risks and substantiate sustainability claims.
ASIC expects risk warnings and qualifiers in financial ads to be clear and prominent enough to correct the impression created by headline claims; hidden or unreadable qualifiers can make an ad misleading.
Prop 65 requires clear and reasonable warnings, visible before purchase including online, for California exposures to listed chemicals; safe-harbor warnings must include the signal word, a named chemical, the endpoint and the P65Warnings URL.
Prop 65 requires clear and reasonable warnings before California exposure to listed chemicals; dietary supplements use the food-warning safe harbor, warnings must name a chemical, and online sales must show the warning before purchase.
Canadian fund ads must not describe a fund's risk in a way that conflicts with its Fund Facts or ETF Facts risk rating or imply guarantees that do not exist.
Request a free compliance scan of your homepage and book a time with Warrant.